Studies in subjects with long-term nonprogressive human immunodeficiency virus infection
- PMID: 7808486
- DOI: 10.1056/NEJM199501263320402
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection
Abstract
Background: In a small percentage of persons infected with human immunodeficiency virus type 1 (HIV-1), there is no progression of disease and CD4+ T-cell counts remain stable for many years. Studies of the histopathological, virologic, and immunologic characteristics of these persons may provide insight into the pathogenic mechanisms that lead to HIV disease and the protective mechanisms that prevent progression to overt disease.
Methods and results: We studied 15 subjects with long-term nonprogressive HIV infection and 18 subjects with progressive HIV disease. Nonprogressive infection was defined as seven or more years of documented HIV infection, with more than 600 CD4+ T cells per cubic millimeter, no antiretroviral therapy, and no HIV-related disease. Lymph nodes from the subjects with nonprogressive infection had significantly fewer of the hyperplastic features, and none of the involuted features, characteristic of nodes from subjects with progressive disease. Plasma levels of HIV-1 RNA and the viral burden in peripheral-blood mononuclear cells were both significantly lower in the subjects with nonprogressive infection than in those with progressive disease (P = 0.003 and P = 0.015, respectively). HIV could not be isolated from the plasma of the former, who also had significantly higher titers of neutralizing antibodies than the latter. There was viral replication, however, in the subjects with nonprogressive infection, and virus was consistently cultured from mononuclear cells from the lymph nodes. In the lymph nodes virus "trapping" varied with the degree of formation of germinal centers, and few cells expressing virus were found by in situ hybridization. HIV-specific cytotoxic activity was detected in all seven subjects with nonprogressive infection who were tested.
Conclusions: In persons who remain free of disease for many years despite HIV infection the viral load is low, but viral replication persists. Lymph-node architecture and immune function appear to remain intact.
Comment in
-
Long-term survivors of human immunodeficiency virus type 1 infection.N Engl J Med. 1995 Jun 15;332(24):1646-7; author reply 1647-8. doi: 10.1056/NEJM199506153322412. N Engl J Med. 1995. PMID: 7646661 No abstract available.
-
Long-term survivors of human immunodeficiency virus type 1 infection.N Engl J Med. 1995 Jun 15;332(24):1647; author reply 1647-8. N Engl J Med. 1995. PMID: 7753147 No abstract available.
-
Long-term survivors of human immunodeficiency virus type 1 infection.N Engl J Med. 1995 Jun 15;332(24):1647; author reply 1647-8. N Engl J Med. 1995. PMID: 7753149 No abstract available.
-
Lessons from people with nonprogressive HIV infection.N Engl J Med. 1995 Jan 26;332(4):259-60. doi: 10.1056/NEJM199501263320410. N Engl J Med. 1995. PMID: 7808493 No abstract available.
Similar articles
-
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.N Engl J Med. 1995 Jan 26;332(4):201-8. doi: 10.1056/NEJM199501263320401. N Engl J Med. 1995. PMID: 7808485
-
Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort.N Engl J Med. 1999 Jun 3;340(22):1715-22. doi: 10.1056/NEJM199906033402203. N Engl J Med. 1999. PMID: 10352163
-
Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.N Engl J Med. 1997 Oct 30;337(18):1267-74. doi: 10.1056/NEJM199710303371803. N Engl J Med. 1997. PMID: 9345075
-
Molecular biological assessment methods and understanding the course of the HIV infection.APMIS Suppl. 2003;(114):1-37. APMIS Suppl. 2003. PMID: 14626050 Review.
-
New concepts in the immunopathogenesis of HIV infection.Annu Rev Immunol. 1995;13:487-512. doi: 10.1146/annurev.iy.13.040195.002415. Annu Rev Immunol. 1995. PMID: 7612232 Review.
Cited by
-
Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs.Sci Rep. 2015 Jul 7;5:11856. doi: 10.1038/srep11856. Sci Rep. 2015. PMID: 26150163 Free PMC article.
-
The challenge of immune control of immunodeficiency virus.J Clin Invest. 1999 Sep;104(6):677-8. doi: 10.1172/JCI8242. J Clin Invest. 1999. PMID: 10491402 Free PMC article. No abstract available.
-
Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virus.J Virol. 2000 Dec;74(24):11744-53. doi: 10.1128/jvi.74.24.11744-11753.2000. J Virol. 2000. PMID: 11090174 Free PMC article.
-
Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge.J Virol. 2000 Mar;74(6):2502-9. doi: 10.1128/jvi.74.6.2502-2509.2000. J Virol. 2000. PMID: 10684264 Free PMC article.
-
Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.Front Immunol. 2019 Dec 18;10:2968. doi: 10.3389/fimmu.2019.02968. eCollection 2019. Front Immunol. 2019. PMID: 31921207 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials